心血管疾病中沉默调节蛋白介导的自噬的研究现状
The Current State of Research on Sirtuin-Mediated Autophagy in Cardiovascular Diseases.
作者信息
Wang Yuqin, Li Yongnan, Ding Hong, Li Dan, Shen Wanxi, Zhang Xiaowei
机构信息
The Second Clinical Medical College, Lanzhou University, Lanzhou 730106, China.
Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou 730031, China.
出版信息
J Cardiovasc Dev Dis. 2023 Sep 6;10(9):382. doi: 10.3390/jcdd10090382.
Sirtuins belong to the class III histone deacetylases and possess nicotinamide adenine dinucleotide-dependent deacetylase activity. They are involved in the regulation of multiple signaling pathways implicated in cardiovascular diseases. Autophagy is a crucial adaptive cellular response to stress stimuli. Mounting evidence suggests a strong correlation between Sirtuins and autophagy, potentially involving cross-regulation and crosstalk. Sirtuin-mediated autophagy plays a crucial regulatory role in some cardiovascular diseases, including atherosclerosis, ischemia/reperfusion injury, hypertension, heart failure, diabetic cardiomyopathy, and drug-induced myocardial damage. In this context, we summarize the research advancements pertaining to various Sirtuins involved in autophagy and the molecular mechanisms regulating autophagy. We also elucidate the biological function of Sirtuins across diverse cardiovascular diseases and further discuss the development of novel drugs that regulate Sirtuin-mediated autophagy.
沉默调节蛋白属于Ⅲ类组蛋白脱乙酰酶,具有烟酰胺腺嘌呤二核苷酸依赖性脱乙酰酶活性。它们参与多种与心血管疾病相关的信号通路的调节。自噬是细胞对应激刺激的一种关键适应性反应。越来越多的证据表明沉默调节蛋白与自噬之间存在密切关联,可能涉及交叉调节和相互作用。沉默调节蛋白介导的自噬在某些心血管疾病中发挥关键调节作用,包括动脉粥样硬化、缺血/再灌注损伤、高血压、心力衰竭、糖尿病性心肌病和药物性心肌损伤。在此背景下,我们总结了与参与自噬的各种沉默调节蛋白以及调节自噬的分子机制相关的研究进展。我们还阐明了沉默调节蛋白在多种心血管疾病中的生物学功能,并进一步讨论了调节沉默调节蛋白介导的自噬的新型药物的开发。